Cargando…
Multiple mechanisms of MYCN dysregulation in Wilms tumour
Genomic gain of the proto-oncogene transcription factor gene MYCN is associated with poor prognosis in several childhood cancers. Here we present a comprehensive copy number analysis of MYCN in Wilms tumour (WT), demonstrating that gain of this gene is associated with anaplasia and with poorer relap...
Autores principales: | Williams, Richard D., Chagtai, Tasnim, Alcaide-German, Marisa, Apps, John, Wegert, Jenny, Popov, Sergey, Vujanic, Gordan, van Tinteren, Harm, van den Heuvel-Eibrink, Marry M., Kool, Marcel, de Kraker, Jan, Gisselsson, David, Graf, Norbert, Gessler, Manfred, Pritchard-Jones, Kathy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466681/ https://www.ncbi.nlm.nih.gov/pubmed/25749049 |
Ejemplares similares
-
Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study
por: Chagtai, Tasnim, et al.
Publicado: (2016) -
Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour
por: Charlton, Jocelyn, et al.
Publicado: (2015) -
The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
por: Vujanić, Gordan M., et al.
Publicado: (2018) -
Publisher Correction: The UMBRELLA SIOP–RTSG 2016 Wilms tumour pathology and molecular biology protocol
por: Vujanić, Gordan M., et al.
Publicado: (2019) -
TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia
por: Maschietto, Mariana, et al.
Publicado: (2014)